







To find out why GuruFocus thinks data on insider trade are interesting, read
| Symbol | Company | Insider | Position | Date | Buy/Sell | Shares | Trade Price ($) | Cost ($1000) | Price Change Since Trade (%) |
Yield (%) | P/E | Market Cap ($M) | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | ISIS | Isis Pharmaceut... | BENNETT C FRANK | SVP, Antisense Research | 2013-05-01 | Sell | 59,945 | $22.38 | 1341.6 | -7.69 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | CROOKE STANLEY T | Chairman, CEO and President (Click for the stocks that their CEOs have bought) | 2013-04-24 | Sell | 10,000 | $22.12 | 221.2 | -6.6 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | HOUGEN ELIZABETH L | SVP, Finance & CFO | 2013-04-24 | Sell | 10,417 | $22.38 | 233.1 | -7.69 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | PARSHALL B LYNNE | COO, Secretary | 2013-04-25 | Sell | 55,854 | $22.29 | 1245 | -7.31 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | Geary Richard S | SVP, Development | 2013-04-19 | Sell | 2,042 | $20.8 | 42.5 | -0.67 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | HOUGEN ELIZABETH L | SVP, Finance & CFO | 2013-04-22 | Sell | 17,656 | $21.46 | 378.9 | -3.73 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | CROOKE STANLEY T | Chairman, CEO and President | 2013-04-23 | Sell | 90,000 | $21.03 | 1892.7 | -1.76 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | Monia Brett P | SVP, Antisense Drug Discovery | 2013-04-22 | Sell | 19,500 | $21.26 | 414.6 | -2.82 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | PARSHALL B LYNNE | COO, Secretary | 2013-04-23 | Sell | 90,000 | $21.03 | 1892.7 | -1.76 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-04-23 | Sell | 42,320 | $21.5 | 909.9 | -3.91 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | Geary Richard S | Sr VP, Development | 2013-04-11 | Sell | 7,000 | $19.52 | 136.6 | 5.84 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2013-04-12 | Sell | 5,460 | $19.61 | 107.1 | 5.35 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2013-03-21 | Sell | 9,000 | $19.26 | 173.3 | 7.27 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | Geary Richard S | Sr VP, Development | 2013-03-21 | Sell | 1,000 | $19.5 | 19.5 | 5.95 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | KLEIN JOSEPH III | Director | 2013-03-20 | Sell | 42,776 | $18 | 770 | 14.78 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | KLEIN JOSEPH III | Director | 2013-03-20 | Sell | 3,924 | $18 | 70.6 | 14.78 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | HOUGEN ELIZABETH L | SVP, Finance and CFO | 2013-03-20 | Sell | 14,376 | $18.13 | 260.6 | 13.95 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | KLEIN JOSEPH III | Director | 2013-03-13 | Sell | 20,800 | $18.01 | 374.6 | 14.71 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | Monia Brett P | SVP, Antisense Drug Discovery | 2013-03-05 | Sell | 18,240 | $16.86 | 307.5 | 22.54 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | HOUGEN ELIZABETH L | SVP, Finance and CFO | 2013-03-05 | Sell | 5,040 | $16.86 | 85 | 22.54 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2013-03-04 | Sell | 11,700 | $15.82 | 185.1 | 30.59 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-02-19 | Sell | 1,950 | $14.8 | 28.9 | 39.59 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-02-13 | Sell | 6,239 | $14.17 | 88.4 | 45.8 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2013-01-30 | Sell | 2,300 | $14.63 | 33.6 | 41.22 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | CROOKE STANLEY T | Chairman, CEO and President | 2013-01-16 | Sell | 1,460 | $14 | 20.4 | 47.57 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2013-01-04 | Sell | 1,296 | $10.76 | 13.9 | 92.01 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | Geary Richard S | Sr VP, Development | 2012-12-13 | Sell | 6,000 | $9.63 | 57.8 | 114.54 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | CROOKE STANLEY T | Chairman, CEO and President | 2012-09-21 | Sell | 89,462 | $14.63 | 1308.8 | 41.22 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | CROOKE STANLEY T | Chairman, CEO and President | 2012-09-13 | Sell | 27,074 | $14.55 | 393.9 | 41.99 | 0.00 | 0.00 | 2092.21 | |
![]() | ISIS | Isis Pharmaceut... | PARSHALL B LYNNE | COO, Secretary | 2012-09-07 | Sell | 12,506 | $15.12 | 189.1 | 36.64 | 0.00 | 0.00 | 2092.21 |
| Guru Name | Portfolio Date* | Current Shares (?) | % of Total Assets (?) | Change from Last Holdings (?) | |
|---|---|---|---|---|---|
| Louis Moore Bacon | 2013-03-31 | 125,000 | 0.03% | New Buy | |
| Murray Stahl | 2013-03-31 | 17,000 | 0% | -41.38% | |
| Steven Cohen | 2013-03-31 | 19,433 | 0% | New Buy | |
Most recent portfolio changes are included for Premium Members only!
| |||||
Add Notes, Comments or Ask Questions
Comments